Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.58 |
| ▸ | FASN | P49327 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 5/20 | 0.56 |
| ▸ | PPARA | Q07869 | 5/20 | 0.56 |
| ▸ | TERT | O14746 | 3/20 | 0.55 |
| ▸ | PPARD | Q03181 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8443714 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL8441219 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL8444866 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL1129290 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL8440676 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL6903523 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL1129945 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL6903526 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL8441217 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT | |
| SCHEMBL1491161 | 1.00 | PTPN1 (0.58) | PTPN1FASNPPARGPPARATERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10526563-B2 | Mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | SYMRISE AG (DE) | 2020-01-07 | — | — | US | disclosed |
| US-20170114299-A1 | New mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | SYMRISE AG (DE) | 2017-04-27 | — | — | US | disclosed |
| EP-3122316-A1 | OIL-IN-WATER EMULSIONS CONTAINING 4-HYDROXYACETOPHENONE AND ANIONIC EMULSIFIERS | Symrise AG (DE) | 2017-02-01 | — | — | EP | disclosed |
| WO-2015144333-A1 | OIL-IN-WATER EMULSIONS CONTAINING 4-HYDROXYACETOPHENONE AND ANIONIC EMULSIFIERS | BEIERSDORF AG (DE) | 2015-10-01 | — | — | WO | disclosed |
| EP-0814660-B1 | TOPICAL ANTIMICROBIAL AGENTS | RES CORP TECHNOLOGIES INC (US) | 1999-06-23 | — | — | EP | disclosed |
| EP-0814660-A1 | TOPICAL ANTIMICROBIAL AGENTS | Research Corporation Technologies, Inc (US) | 1998-01-07 | — | — | EP | disclosed |
| US-5610196-A | METHYL UNSATURATED LONG-CHAIN ALKYL KETONE, ACNE | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-03-11 | — | — | US | disclosed |
| US-5604262-A | UNSATURATED ALKYL KETONE | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-02-18 | — | — | US | disclosed |
| WO-1996028975-A1 | TOPICAL ANTIMICROBIAL AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10526563-B2 | Mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | OR51E2, OR10J3, TAS2R7 | PTPN1 2879/4885FASN 2458/4885PPARG 2441/4885 |
| US-20170114299-A1 | New mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | OR51E2, OR10J3, TAS2R7 | PTPN1 2867/4885FASN 2368/4885PPARG 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.